We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+5.04%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.02%
AUM
$9.85B
AUM Growth
+$544M
Cap. Flow
+$305M
Cap. Flow %
3.1%
Top 10 Hldgs %
10.6%
Holding
1,507
New
131
Increased
296
Reduced
233
Closed
100

Top Sells

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$70.2M
2
SRE icon
Sempra
SRE
+$62.5M
3
LNC icon
Lincoln National
LNC
+$62.2M
4
XL
XL Group Ltd.
XL
+$60.6M
5
NEE icon
NextEra Energy
NEE
+$58.5M

Sector Composition

Rank Sector Weight
1 Financials 23.55%
2 Industrials 12.89%
3 Consumer Discretionary 12.47%
4 Healthcare 10.29%
5 Technology 10.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XONE
1226
DELISTED
The ExOne Company
XONE
$342K ﹤0.01%
+48,300
New +$339K
PBBI
1227
DELISTED
PB Bancorp, Inc. Common Stock
PBBI
$341K ﹤0.01%
30,000
PTGX icon
1228
Protagonist Therapeutics
PTGX
$8.79B
$340K ﹤0.01%
50,600
+11,600
+30% +$89.1K
GST
1229
DELISTED
Gastar Exploration Inc.
GST
$340K ﹤0.01%
606,338
-240,200
-28% -$158K
BH.A icon
1230
Biglari Holdings Class A
BH.A
$1.25B
$333K ﹤0.01%
+350
New +$349K
KALV
1231
DELISTED
KalVista Pharmaceuticals
KALV
$333K ﹤0.01%
41,000
MPU icon
1232
Mega Matrix
MPU
$16.1M
$333K ﹤0.01%
105,000
CRIS icon
1233
Curis
CRIS
$9.78M
$331K ﹤0.01%
+478
New +$490K
CYPH
1234
Cypherpunk Technologies Inc
CYPH
$62.9M
$327K ﹤0.01%
3,630
ALRM icon
1235
Alarm.com
ALRM
$2.71B
$323K ﹤0.01%
8,000
FLGT icon
1236
Fulgent Genetics
FLGT
$470M
$323K ﹤0.01%
78,100
CBK
1237
DELISTED
Christopher & Banks Corporation
CBK
$323K ﹤0.01%
344,000
-149,800
-30% -$151K
UBFO
1238
DELISTED
United Security Bancshares
UBFO
$322K ﹤0.01%
28,755
SUNE
1239
SUNation Energy
SUNE
$8.95M
0
AIRT icon
1240
Air T
AIRT
$75.5M
$318K ﹤0.01%
14,250
RGR icon
1241
Sturm, Ruger & Co
RGR
$594M
$314K ﹤0.01%
5,600
MACK
1242
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$310K ﹤0.01%
+80,327
New +$533K
SMTX
1243
DELISTED
SMTC Corporation
SMTX
$309K ﹤0.01%
105,000
-21,000
-17% -$57.1K
VVX icon
1244
V2X
VVX
$2.83B
$308K ﹤0.01%
10,000
CCRD
1245
DELISTED
CoreCard
CCRD
$307K ﹤0.01%
35,362
ISEE
1246
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$307K ﹤0.01%
+112,600
New +$311K
IBRX icon
1247
ImmunityBio
IBRX
$7.51B
$306K ﹤0.01%
+100,000
New +$370K
DAIO icon
1248
Data I/O
DAIO
$29.2M
$305K ﹤0.01%
+48,000
New +$339K
OMED
1249
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$302K ﹤0.01%
130,900
+50,000
+62% +$146K
KNDI
1250
Kandi Technologies Group
KNDI
$67.5M
$298K ﹤0.01%
+70,100
New +$354K

Similar funds

Bridgeway Capital Management's Q2 2018 Portfolio in Review

As of Q2 2018, Bridgeway Capital Management held 1,507 positions worth $9.85B, up 5.8% from $9.31B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Bridgeway Capital Management deployed $305M of net new capital in Q2 2018, opening 131 new positions and adding to 296 existing holdings. Its largest new stake was Morgan Stanley: 1,333,400 shares worth $63.2M.

By sector, the portfolio is most concentrated in Financials at 24% of assets, up from 23% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Lam Research, an estimated $70.2M trimmed.

  • Bridgeway Capital Management's largest Q2 2018 buy was Morgan Stanley: 1,333,400 shares worth $63.2M.
  • Bridgeway Capital Management added most to Cigna in Q2 2018, an estimated $58.3M increase.
  • Bridgeway Capital Management's biggest Q2 2018 reduction was Lam Research, cutting an estimated $70.2M.
  • Bridgeway Capital Management fully exited Sempra in Q2 2018, selling an estimated $62.5M.
  • Bridgeway Capital Management's ten largest holdings make up 11% of its $9.85B portfolio in Q2 2018.
  • Bridgeway Capital Management opened 131 new positions and closed 100 in Q2 2018.
  • Bridgeway Capital Management's portfolio value rose 5.8% quarter-over-quarter to $9.85B.

Based on Bridgeway Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.